Literature DB >> 19402636

Electrochemically driven drug metabolism by membranes containing human cytochrome P450.

Yasuhiro Mie1, Masaaki Suzuki, Yasuo Komatsu.   

Abstract

Rapid analyses of drug metabolism reactions by human cytochrome P450s (CYPs) that metabolize 95% of all current drugs are very important in drug development processes and effective therapies. Since CYPs need electrons to metabolize drugs, electrons supplied from electrodes to activate CYP molecules are expected to be very useful to develop rapid assay methods for CYP reactions. Although several studies on the direct electrochemistry of isolated and purified human CYPs have been reported, the use of microsomes (membranes) containing CYP is more suitable, because they are frequently used in drug research due to their easy preparation and low cost. Herein, we demonstrate electrons supplied from an electrode to microsomes containing CYP and CYP-reductase (CPR) on an electrode coated with hydrophobic thin films and observe electrochemically driven drug metabolisms by voltammetry for the first time. We tested the immobilization of microsomes on gold electrodes coated with several thiolates and found that microsomes immobilized on thin hydrophobic surfaces of aromatic compounds showed well-defined redox peaks. Furthermore, electrochemically driven drug metabolism reactions of CYP3A4 were clearly observed by voltammetry, and these reactions were inhibited by a CYP3A4 inhibitor, ketoconazole. We also found that metabolism reactions were facilitated in the presence of CPR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19402636     DOI: 10.1021/ja809364r

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  14 in total

1.  Site-specific fluorescent labeling and oriented immobilization of a triple mutant of CYP3A4 via C64.

Authors:  Amélie Ménard; Yue Huang; Pierre Karam; Gonzalo Cosa; Karine Auclair
Journal:  Bioconjug Chem       Date:  2012-04-02       Impact factor: 4.774

Review 2.  Current Approaches for Investigating and Predicting Cytochrome P450 3A4-Ligand Interactions.

Authors:  Irina F Sevrioukova; Thomas L Poulos
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 3.  Engineering cytochrome P450 enzyme systems for biomedical and biotechnological applications.

Authors:  Zhong Li; Yuanyuan Jiang; F Peter Guengerich; Li Ma; Shengying Li; Wei Zhang
Journal:  J Biol Chem       Date:  2019-12-06       Impact factor: 5.157

4.  Electrocatalysis by subcellular liver fractions bound to carbon nanostructures for stereoselective green drug metabolite synthesis.

Authors:  Rajasekhara Nerimetla; Sadagopan Krishnan
Journal:  Chem Commun (Camb)       Date:  2015-06-23       Impact factor: 6.222

5.  Efficient bioelectronic actuation of the natural catalytic pathway of human metabolic cytochrome P450s.

Authors:  Sadagopan Krishnan; Dhanuka Wasalathanthri; Linlin Zhao; John B Schenkman; James F Rusling
Journal:  J Am Chem Soc       Date:  2011-01-07       Impact factor: 15.419

6.  Bioelectronic delivery of electrons to cytochrome P450 enzymes.

Authors:  Sadagopan Krishnan; John B Schenkman; James F Rusling
Journal:  J Phys Chem B       Date:  2011-05-17       Impact factor: 2.991

Review 7.  Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation.

Authors:  Santosh Kumar
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-02       Impact factor: 4.481

Review 8.  Thin multicomponent films for functional enzyme devices and bioreactor particles.

Authors:  James F Rusling; Dhanuka P Wasalathanthri; John B Schenkman
Journal:  Soft Matter       Date:  2014-11-07       Impact factor: 3.679

9.  Study of drug metabolism by xanthine oxidase.

Authors:  Jing Zhao; Xiaolin He; Nana Yang; Lizhou Sun; Genxi Li
Journal:  Int J Mol Sci       Date:  2012-04-18       Impact factor: 6.208

Review 10.  The Oxygen Dilemma: A Severe Challenge for the Application of Monooxygenases?

Authors:  Dirk Holtmann; Frank Hollmann
Journal:  Chembiochem       Date:  2016-06-30       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.